📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors. (2021)

First Author: Rettman P

Attributed to: Targeting natural killer cell receptors for immunotherapeutic benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2020-001912

PubMed Identifier: 34016721

Publication URI: http://europepmc.org/abstract/MED/34016721

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal for immunotherapy of cancer

Issue: 5

ISSN: 2051-1426